Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies

Transfusion

Volumn 39, Issue 10, 1999, Pages 1145-1149

  Césaire, Raymond ^a,b   Bera, O ^a   Maier, H ^a   Lezin, A ^a   Martial, J ^a   Ouka, M ^a   Kerob Bauchet, B ^a   Ould Amar, A K ^a   Vernant, J C ^a  

^a University Hospital   (Martinique)

^b Center Hospitalier Universitaire   (Martinique)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CROSS REACTION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MARTINIQUE; PATIENT COUNSELING; SEROCONVERSION;

ADULT; BLOOD DONORS; DELTARETROVIRUS ANTIBODIES; DELTARETROVIRUS INFECTIONS; EPIDEMIOLOGIC METHODS; FEMALE; FOLLOW-UP STUDIES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MARTINIQUE; MIDDLE AGED; SEROLOGIC TESTS; TIME FACTORS;

EID: 18144444947     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39101145.x     Document Type: Article

References (25)

1. Blattner WA. Epidemiology of HTLV-I and associated diseases. In: Blattner WA, ed. Human retrovirology: HTLV. New York: Raven Press, 1990;251-63.
2. Lipka JJ, Young KK, Kwok SY, et al. Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals. Vox Sang 1991;61:171-6.
3. Lal RB, Rudolph DL, Coligan JE, et al. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II. Blood 1992;80:544-50.
4. Khabbaz RF, Heneine W, Grindon A, et al. Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II? J Acquir Immune Defic Syndr 1992;5:400-4.
5. Ownby HE, Korelitz JJ, Busch MP, et al. Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. The Retrovirus Epidemiology Donor Study. Transfusion 1997;37:199-205.
6. Delaporte E, Monplaisir N, Louwagie J, et al. Prevalence of HTLV-I and HTLV-II infection in Gabon, Africa: comparison of the serological and PCR results. Int J Cancer 1991;49:373-6.
7. Garin B, Gosselin S, de Thé G, Gessain A. HTLV-I/II infection in a high viral endemic area of Zaïre, Central Africa: comparative evaluation of serology, PCR, and significance of indeterminate western blot pattern. J Med Virol 1994;44:104-9.
8. Tuppin P, Makuwa M, Guerma T, et al. Low HTLV-I/II seroprevalence in pregnant women in Congo and a geographic cluster of an HTLV-like indeterminate Western blot pattern (letter). J Acquir Immune Defic Syndr 1996;11:105-7.
9. Mauclère P, Le Hesran JY, Mahieux R, et al. Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa. J Infect Dis 1997;176:505-9.
10. Yanigihara R, Jenkins CL, Alexander SS, et al. Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis. J Infect Dis 1990;162:649-54.
11. Segurado AA, Malaque CM, Sumita LM, et al. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Am J Trop Med Hyg 1997;57:142-8.
12. Couroucé AM, Pillonel J, Lemaire JM, et al. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS 1993;7:841-7.
13. Schaffar-Deshayes L, Chavance M, Monplaisir N, et al. Antibodies to HTLV-I in p24 sera of blood donors, elderly people and patients with hemopoietic diseases in France and in French West Indies. Int J Cancer 1984;34:667-70.
14. Monplaisir N, Valette I, Dezaphy Y, Neisson-Vernant C. Blood transfusion and HTLV-I infection in Martinique. In: Roman GC, Vernant JC, Osame M, eds. HTLV-I and the nervous system. New York: Liss, 1989;533-9.
15. Goubau P, Van Brussel M, Vandamme AM, et al. A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types I and II, in a wild-caught baboon (Papio hamadryas). Proc Natl Acad Sci U S A 1994;91:2848-52.
16. Nogueira CM, Cavalcanti M, Schechter M, Ferreira OC Jr. Human T lymphotropic virus type I and II infections in healthy blood donors from Rio de Janeiro, Brazil (letter). Vox Sang 1996;70:47-8.
17. Pillonel J, Couroucé AM, Elghouzzi MH, et al. Seroconversions to HTLV in blood donors (letter). Vox Sang 1996;70:47.
18. Manns A, Murphy EL, Wilks R, et al. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood 1991;77:896-905.
19. Chen YM, Gomez-Lucia E, Okayama A, et al. Antibody profile of early HTLV-I infection. Lancet 1990;336:1214-6; erratum appears Lancet 1990;336:1596.
20. Zehender G, Girotto M, De Maddalena C, et al. HTLV infection in ELISA-negative blood donors. AIDS Res Hum Retroviruses 1996;12:737-40.
21. Kubota T, Ikezoe T, Hakoda E, et al. HTLV-I-seronegative, genome-positive adult T-cell leukemia: report of a case. Am J Hematol 1996;53:133-6.
22. Galeno H, Ramirez E, Cartier L. HTLV-I provirus in seronegative Chilean patients with tropical spastic paraparesis (letter). Lancet 1996;548:1170.
23. Zucker-Franklin D, Gorman JG. HTLV-I provirus in seronegative healthy blood donors (letter). Lancet 1997;349:999.
24. Miyata H, Kamahora T, Iha S, et al. Dependency of antibody titer on provirus load in human T lymphotropic virus type I carriers: an interpretation for minor population of seronegative carriers. J Infect Dis 1995;171:1455-60.
25. Gessain A, Mathieux R. HTLV-I "indeterminate" western blot patterns observed in sera from tropical regions: the situation revisited (letter; comment). J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:316-9.